Amanda Gilkes

5.1k total citations
59 papers, 1.8k citations indexed

About

Amanda Gilkes is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Amanda Gilkes has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 28 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Amanda Gilkes's work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Amanda Gilkes is often cited by papers focused on Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Amanda Gilkes collaborates with scholars based in United Kingdom, Denmark and United States. Amanda Gilkes's co-authors include Ken Mills, Alan K. Burnett, Robert K. Hills, Steven Knapper, Nigel H. Russell, Rosemary E. Gale, David Grimwade, Alexander Kohlmann, Lothar Wieczorek and Torsten Haferlach and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Amanda Gilkes

56 papers receiving 1.8k citations

Peers

Amanda Gilkes
Maura Gasparetto United States
Karen Dunn United Kingdom
Livia Manzella Italy
Lothar Wieczorek Germany
Biniam Adane United States
Shalini Verma United States
Frédèrique Verdier France
K C Anderson United States
Iris Breitkreutz United States
Amy de Haar-Holleman Netherlands
Maura Gasparetto United States
Amanda Gilkes
Citations per year, relative to Amanda Gilkes Amanda Gilkes (= 1×) peers Maura Gasparetto

Countries citing papers authored by Amanda Gilkes

Since Specialization
Citations

This map shows the geographic impact of Amanda Gilkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Gilkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Gilkes more than expected).

Fields of papers citing papers by Amanda Gilkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Gilkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Gilkes. The network helps show where Amanda Gilkes may publish in the future.

Co-authorship network of co-authors of Amanda Gilkes

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Gilkes. A scholar is included among the top collaborators of Amanda Gilkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Gilkes. Amanda Gilkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, Nigel H., Jad Othman, Oliver Cumming, et al.. (2025). Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3 -mutated AML. Blood Advances. 9(24). 6455–6466.
2.
Othman, Jad, Nicola Potter, Adam Ivey, et al.. (2024). Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood. 143(19). 1931–1936. 33 indexed citations
3.
Loo, Sun, Richard Dillon, Adam Ivey, et al.. (2022). Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome. Blood. 140(22). 2407–2411. 42 indexed citations
4.
Menezes, Ana Catarina, Rachel Jones, R.I. Nicholson, et al.. (2022). Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia. 36(7). 1769–1780. 10 indexed citations
5.
Nicholson, R.I., Ana Catarina Menezes, Claire Seedhouse, et al.. (2022). Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux. Frontiers in Oncology. 12. 840046–840046. 8 indexed citations
6.
7.
Rastogi, Namrata, Vikas Srivastava, Amanda Gilkes, et al.. (2022). Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia. 37(2). 276–287. 3 indexed citations
8.
Biernacka, Kalina, Rachel Barker, Hanna Zielińska, et al.. (2021). Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer. Cancers. 13(4). 825–825. 6 indexed citations
9.
Linch, David C., Robert K. Hills, Amanda Gilkes, et al.. (2021). Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia. Leukemia Research. 108. 106553–106553. 1 indexed citations
10.
Tiong, Ing Soo, Richard Dillon, Adam Ivey, et al.. (2020). The Natural History of NPM1MUT Measurable Residual Disease (MRD) Positivity after Completion of Chemotherapy in Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 25–27. 3 indexed citations
11.
12.
McMullin, M. F., Ken Mills, Robert K. Hills, et al.. (2009). THE PROGNOSTIC ROLE OF C-FLIP IN AML. 94. 108–108. 1 indexed citations
13.
Jenkins, Christopher, Saman Hewamana, Amanda Gilkes, et al.. (2008). Nuclear factor‐κB as a potential therapeutic target for the novel cytotoxic agent LC‐1 in acute myeloid leukaemia. British Journal of Haematology. 143(5). 661–671. 20 indexed citations
14.
Walsby, Elisabeth, Amanda Gilkes, Amanda J. Tonks, et al.. (2008). Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling. British Journal of Haematology. 141(4). 483–493. 40 indexed citations
15.
Walsby, Elisabeth, Amanda Gilkes, Alex Tonks, Richard L. Darley, & Ken Mills. (2007). FUS expression alters the differentiation response to all‐trans retinoic acid in NB4 and NB4R2 cells. British Journal of Haematology. 139(1). 94–97. 5 indexed citations
16.
Mills, Ken & Amanda Gilkes. (2006). Clinical implications of gene expression profiling of acute myeloid leukemia. Current Hematologic Malignancy Reports. 1(2). 114–121. 1 indexed citations
17.
Grimwade, David, R P Gale, Robert K. Hills, et al.. (2003). The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia.. Blood. 102(11). 3 indexed citations
18.
Mills, Ken, Amanda Gilkes, Marion Sweeney, et al.. (1998). Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells. FEBS Letters. 440(1-2). 158–162. 20 indexed citations
19.
Gilkes, Amanda, Simon Guild, & Gordon Cramb. (1994). Phorbol Ester Activation of Protein Kinase C Inhibits CNP-Stimulated Cyclic-GMP Production in the Mouse AtT-20 Pituitary Tumor Cell Line. Biochemical and Biophysical Research Communications. 204(3). 1318–1324. 6 indexed citations
20.
Gilkes, Amanda, et al.. (1993). nir1, a conditional-lethal mutation in barley causing a defect in nitrite reduction. Molecular and General Genetics MGG. 236-236(2-3). 275–282. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maura Gasparetto Breakdown of academic impact, for papers by Karen Dunn Breakdown of academic impact, for papers by Livia Manzella Breakdown of academic impact, for papers by Lothar Wieczorek Breakdown of academic impact, for papers by Biniam Adane Breakdown of academic impact, for papers by Shalini Verma Breakdown of academic impact, for papers by Frédèrique Verdier Breakdown of academic impact, for papers by K C Anderson Breakdown of academic impact, for papers by Iris Breitkreutz Breakdown of academic impact, for papers by Amy de Haar-Holleman
Rankless by CCL
2026